Historical Background

Med Discovery is a Swiss private biotech company founded in 2002 as a spin-off of the Vaudois University Hospital Centre (CHUV) in Lausanne, Switzerland.

A team of three biologists and three urologists have shared their competencies to create the Onco Urology Company named Med Discovery.

By combining biological drug discovery expertise with a strong in-house knowledge of the medical urology field, Med Discovery is uniquely positioned to develop novel drugs for urological cancers and other related solid tumors.